It smells!!! Investors know something that other investors do no know!!!! $13.5 that's the closing price in TASE in 5M NIS volume when the general index goes up. SEC should be involved here. Someone can shed some light?
Folks here might want to have a look on Sciclone pharmaceuticals - it's another biotech, from california, ticker SCLN. They deal with cancer & hepatitis, phase 3 studies, $40M yearly sales, $90M market cap. A pretty attractive biotech imo.